Kristina Hamel

Title: Kristina Hamel: Innovator in Neuropilin-2 Research

Introduction

Kristina Hamel is a prominent inventor based in San Diego, CA, known for her significant contributions to the field of biomedical research. With a focus on neuropilin-2 (NRP2), her work has led to the development of innovative therapeutic compositions aimed at treating diseases associated with this protein.

Latest Patents

Kristina Hamel holds two patents related to compositions and methods comprising anti-NRP2 antibodies. These patents provide antibodies and antigen-binding fragments that specifically bind to human neuropilin-2 polypeptides. The inventions include methods that modulate binding interactions between human NRP2 and its ligands, such as human histidyl-tRNA synthetase (HRS). This modulation can influence downstream signaling events mediated by NRP2, offering potential therapeutic applications for treating NRP2-associated diseases.

Career Highlights

Hamel is currently associated with Atyr Pharma, Inc., where she continues her research and development efforts. Her work is pivotal in advancing the understanding of NRP2 and its implications in various diseases.

Collaborations

Some of her notable coworkers include Luke Burman and Yee Ting (Esther) Chong, who contribute to her research endeavors and collaborative projects.

Conclusion

Kristina Hamel's innovative work in the field of neuropilin-2 research exemplifies the impact of dedicated inventors in advancing medical science. Her patents and ongoing research hold promise for developing new therapeutic strategies for challenging diseases.